Skip to main content

News Archive

News Archive - Yadira Galindo

UC San Diego Receives $9 Million in Grants to Pinpoint Cellular Cause of Type 1 Diabetes

August 13, 2019

UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.

Men Taking Medications for Enlarged Prostate Face Delays in Prostate Cancer Diagnosis

May 6, 2019

University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

April 22, 2019

University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 1, 2019

Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.

Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth

March 13, 2019

New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.

UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest

February 5, 2019

To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.

UC San Diego Researchers Identify How Skin Ages, Loses Fat and Immunity

December 26, 2018

Some dermal fibroblasts can convert into fat cells that reside under the dermis, giving skin a youthful look and producing peptides that fight infections. University of California San Diego School of Medicine researchers and colleagues show how this happens and what causes it to stop as people age.

UC San Diego Researchers Identify How Skin Ages, Loses Fat and Immunity

December 26, 2018

Some dermal fibroblasts can convert into fat cells that reside under the dermis, giving skin a youthful look and producing peptides that fight infections. University of California San Diego School of Medicine researchers and colleagues show how this happens and what causes it to stop as people age.

UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread

December 7, 2018

David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.

UC San Diego Researchers Develop Sensors to Detect and Measure Cancer’s Ability to Spread

December 5, 2018

University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer.
Category navigation with Social links